Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$373M |
| 2 |
Costco
COST
|
+$283M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$270M |
| 4 |
Pfizer
PFE
|
+$240M |
| 5 |
Microsoft
MSFT
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$274M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$228M |
| 3 |
GAS
AGL Resources Inc
GAS
|
+$216M |
| 4 |
TE
TECO ENERGY INC
TE
|
+$136M |
| 5 |
Charter Communications
CHTR
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.75% |
| 2 | Healthcare | 13.12% |
| 3 | Financials | 12.46% |
| 4 | Consumer Staples | 9.7% |
| 5 | Industrials | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
B
26
Barrick Mining
B
$65.3B
| $201M | 0.36% |
11,343,002
-6,132,500
| -35% | -$122M |
2014 Q2
9 quarters
|
|
27
Novartis
NVS
$272B
| $199M | 0.35% |
2,806,849
+284,022
| +11% | +$20.7M |
2013 Q3
12 quarters
|
|
28
Sysco
SYY
$38.7B
| $189M | 0.33% |
3,861,400
+2,768,700
| +253% | +$142M |
2015 Q3
4 quarters
|
|
29
F5
FFIV
$26.3B
| $189M | 0.33% |
1,518,074
+154,900
| +11% | +$18.8M |
2014 Q3
8 quarters
|
|
30
FirstEnergy
FE
$25.9B
| $189M | 0.33% |
5,708,500
+1,682,692
| +42% | +$57.2M |
2014 Q1
10 quarters
|
|
31
AstraZeneca
AZN
$246B
| $187M | 0.33% |
2,851,350
-131,700
| -4% | -$8.61M |
2013 Q2
13 quarters
|
|
32
Nike
NKE
$51.3B
| $187M | 0.33% |
3,556,300
-1,510,200
| -30% | -$85.3M |
2016 Q2
1 quarter
|
|
33
Sempra
SRE
$52.4B
| $183M | 0.32% |
3,416,200
-490,800
| -13% | -$26.7M |
2014 Q3
8 quarters
|
|
34
Altria Group
MO
$119B
| $182M | 0.32% |
2,882,800
+2,121,982
| +279% | +$141M |
2014 Q1
10 quarters
|
|
35
eBay
EBAY
$49.3B
| $180M | 0.32% |
5,474,640
+2,472,900
| +82% | +$74.7M |
2015 Q4
3 quarters
|
|
|
BCR
36
DELISTED
CR Bard Inc.
BCR
| $179M | 0.32% |
797,200
-266,000
| -25% | -$59.9M |
2013 Q2
13 quarters
|
|
37
Herbalife
HLF
$1.35B
| $178M | 0.32% |
5,757,800
-554,200
| -9% | -$17.5M |
2015 Q3
4 quarters
|
|
38
Edwards Lifesciences
EW
$48B
| $178M | 0.31% |
4,429,218
-2,212,182
| -33% | -$83.3M |
2014 Q2
9 quarters
|
|
39
Kroger
KR
$36.2B
| $177M | 0.31% |
5,963,600
+3,884,500
| +187% | +$129M |
2016 Q2
1 quarter
|
|
40
Johnson & Johnson
JNJ
$616B
| $174M | 0.31% |
1,475,100
+849,000
| +136% | +$103M |
2015 Q3
4 quarters
|
|
41
National Grid
NGG
$77.4B
| $174M | 0.31% |
2,533,806
+119,719
| +5% | +$8.28M |
2013 Q2
13 quarters
|
|
42
Crown Castle
CCI
$29.2B
| $172M | 0.3% |
1,826,200
+992,800
| +119% | +$95.5M |
2015 Q1
6 quarters
|
|
43
Ryanair
RYAAY
$28.1B
| $171M | 0.3% |
5,710,270
-665,250
| -10% | -$19.3M |
2013 Q2
13 quarters
|
|
44
Devon Energy
DVN
$54B
| $170M | 0.3% |
3,844,200
+319,800
| +9% | +$13M |
2016 Q1
2 quarters
|
|
45
Humana
HUM
$46.5B
| $162M | 0.29% |
913,704
+206,904
| +29% | +$35.9M |
2015 Q2
5 quarters
|
|
46
Alaska Air
ALK
$4.41B
| $160M | 0.28% |
2,435,500
-721,400
| -23% | -$47.4M |
2013 Q2
13 quarters
|
|
47
Allegiant Air
ALGT
$2.07B
| $157M | 0.28% |
1,186,800
+27,800
| +2% | +$3.78M |
2013 Q2
13 quarters
|
|
48
Welltower
WELL
$162B
| $154M | 0.27% |
2,061,500
+1,400
| +0.1% | +$107K |
2014 Q3
8 quarters
|
|
49
Gilead Sciences
GILD
$182B
| $154M | 0.27% |
1,947,048
+867,700
| +80% | +$70.5M |
2014 Q4
7 quarters
|
|
50
Oracle
ORCL
$414B
| $153M | 0.27% |
3,883,732
+2,074,600
| +115% | +$84.5M |
2016 Q2
1 quarter
|
|
Similar funds
Renaissance Technologies's Q3 2016 Portfolio in Review
As of Q3 2016, Renaissance Technologies held 3,713 positions worth $56.6B, up 7.7% from $52.5B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Renaissance Technologies deployed $1.92B of net new capital in Q3 2016, opening 413 new positions and adding to 1,833 existing holdings. Its largest new stake was FedEx: 811,400 shares worth $142M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was CVS Health, an estimated $274M trimmed.
- Renaissance Technologies's largest Q3 2016 buy was FedEx: 811,400 shares worth $142M.
- Renaissance Technologies added most to Alphabet (Google) Class A in Q3 2016, an estimated $373M increase.
- Renaissance Technologies's biggest Q3 2016 reduction was CVS Health, cutting an estimated $274M.
- Renaissance Technologies fully exited EMC CORPORATION in Q3 2016, selling an estimated $228M.
- Renaissance Technologies's ten largest holdings make up 7.9% of its $56.6B portfolio in Q3 2016.
- Renaissance Technologies opened 413 new positions and closed 416 in Q3 2016.
- Renaissance Technologies's portfolio value rose 7.7% quarter-over-quarter to $56.6B.
Based on Renaissance Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.